Rhythm Pharmaceuticals, Inc. SEC filings RYTM
Rhythm Pharmaceuticals, Inc. has 837 filings in SEC EDGAR's recent list, going back to Aug 12, 2015. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFR14A | Filing | Aug 7, 2024 | — |
| EFFECT | Filing | Nov 15, 2021 | — |
| CORRESP | Letter to the SEC | Nov 10, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2021 | — |
| CT ORDER | Filing | Aug 17, 2020 | — |
| EFFECT | Filing | Jun 20, 2018 | — |
| CORRESP | Letter to the SEC | Jun 18, 2018 | — |
| CORRESP | Letter to the SEC | Jun 18, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2018 | — |
| DRS | Filing | Jun 11, 2018 | — |
| CT ORDER | Filing | Jun 5, 2018 | — |
| CT ORDER | Filing | Oct 5, 2017 | — |
| EFFECT | Filing | Oct 4, 2017 | — |
| CERTNAS | Auto-generated paper document | Oct 3, 2017 | — |
| CORRESP | Letter to the SEC | Oct 2, 2017 | — |
| CORRESP | Letter to the SEC | Oct 2, 2017 | — |
| 8-A12B | Filing | Sep 29, 2017 | — |
| CORRESP | Letter to the SEC | Sep 27, 2017 | — |
| CORRESP | Letter to the SEC | Sep 27, 2017 | — |
| CORRESP | Letter to the SEC | Sep 18, 2017 | — |
| DRSLTR | Filing | Aug 23, 2017 | — |
| DRS/A | Filing | Aug 23, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2017 | — |
| DRS/A | Filing | May 24, 2017 | — |
| DRSLTR | Filing | May 23, 2017 | — |
| D | Filing | Jan 20, 2017 | — |
| UPLOAD | Letter from the SEC | May 3, 2016 | — |
| DRSLTR | Filing | Apr 6, 2016 | — |
| DRS/A | Filing | Apr 6, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2015 | — |
| D/A | Filing | Dec 10, 2015 | — |
| DRSLTR | Filing | Dec 9, 2015 | — |
| DRS/A | Filing | Dec 9, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2015 | — |
| DRS | Filing | Oct 13, 2015 | — |
| D | Filing | Aug 12, 2015 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RYTM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1649904
- Former names
- RHYTHM METABOLIC, INC. (until Aug 12, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.